Open Now And You Won’t Be Sorry!
ShamrockStocks Newsletter
We`re Only Giving You Winners! Do your home work and always make sure you speak with your registered advisor before you make any decision.
Read NowAnd You Won`t Be Sorry! [1]www.shamrockstocks.com About Convenience TV Inc. (CRPZ.OB) Had a GREAT close yesterday! Be on HIGH ALERT! News Today: [2]Convenience TV Completes 6 Installations in Chicago Convenience TV is focused on the Convenience Store Industry and provides their clients with an “in-location” TV network. The Network is designed to deliver both entertaining content and targeted advertising on a demographic basis to each retail location. In addition, the Network delivers promotional advertising tied to products within the retail location.
The programming can be up-dated quickly and is tailored to meet the specific clients` need for increased sales, customer enjoyment and brand reinforcement.
About Tree Top Industries, Inc. – (OTCBB:TTII) Look for movement! News Today: [3]Tree Top Industries Concentrates Efforts on Build Out of Hazardous Waste Destruction Unit Tree Top`s subsidiaries and affiliates include clean-tech energy, bio-energy and green energy solutions and health care companies. Tree Top is an early stage company that is animating its subsidiaries and affiliates concurrently, as it simultaneously moves to acquire companies that are in various stages of development.
For more information, visit [4]www.ttiiob.com.
About Generex Biotechnology Corporation – (NASDAQ:GNBT) Pay attention traders!!! Recent News: [5]Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board Generex is engaged in the research, development and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs).
The Company`s proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company`s proprietary RapidMist(TM) device.
The Company`s flagship product, oral insulin (Generex Oral-lyn(TM)), which has been launched in India, Lebanon, Algeria, and Ecuador for the treatment of subjects with Type-1 and Type-2 diabetes, is in Phase III clinical trials at several sites around the world. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutics for the treatment of malignant, infectious, allergic, and autoimmune diseases.
For more information, visit the Generex website at [6]www.generex.com or the Antigen Express website at [7]www.antigenexpress.com.
The Shamrockstocks Team [8]http://shamrockstocks.com/disclaimer.html Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
*****************
*
Make sure you always do your own research and consult with your own financial professional The disclaimer is to be read and fully understood before using our site, or joining our email list.
The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due dilligence and consult a financial professional. Shamrockstocks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. The owners of Shamrockstocks.com have been compensated a total of $16,000 from Generex Biotechnology Corp. We have extended our agreement and have recieved an additional $24,000 from GNBT. In the past, we were compensated 100,000 free trading shares of TTII from a 3rd party, Selnic Corp. Our agreement has ended and we own zero shares of TTII. We have not been compensated for coverage on CRPZ. All information on featured companies is provided by the companies profiled, or is available from public sources and Shamrockstocks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.
Shamrockstocks.com nor any of its affiliates are not registered investment advisors or a broker dealers. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead, Shamrockstocks.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks.
References 1. http://www.shamrockstocks.com/
2. http://finance.yahoo.com/news/Convenience-TV-Completes-6-iw-3878386442.htmlx=0&.v=1 3. http://finance.yahoo.com/news/Tree-Top-Industries-pz-3990870455.htmlx=0&.v=1 4. http://www.ttiiob.com/
5. http://finance.yahoo.com/news/Generex-Biotechnology-prnews-322489918.htmlx=0&.v 6. http://www.generex.com/
7. http://www.antigenexpress.com/
8. http://shamrockstocks.com/disclaimer.html This message was sent by: Shamrockstocks.com, 1 Grove St. STE 217 , Pittsford, NY 14534
Related posts:
- Open Now And You Won’t Be Sorry!
- Open Now And You Won’t Be Sorry!
- Wednesday Report – Mid Day
- Wednesday, September 22th, 2010
- Generex Announces Sales Agreement with Elias Shaker & Company